Bioassays for Antibodies
A special issue of Antibodies (ISSN 2073-4468).
Deadline for manuscript submissions: closed (30 December 2020) | Viewed by 341
Special Issue Editor
Interests: monoclonal antibodies; cell-based bioassays; biosimilars; Fc-effector functions; antibody effector-function; standarisation; safety and efficacy of biotherapeutic monoclonal antibodies; immunogencity of biotherapeutics
Special Issue Information
Dear Colleagues,
Bioassays are essential for characterising the biological activity of structurally complex glycoproteins like antibodies. From their biological function and mechanism(s) of action to their regulatory role in ensuring antibody product consistency, bioassays are fundamental to the therapeutic antibody life-cycle. Today, advances in technology, novel assay platforms, standardisation, and new trends in data analysis address from various perspectives some of the historical challenges of variability and sensitivity in cell-based assays. This Special Issue aims to review current developments in the field and seeks contributions that either describe new bioassay platforms or review classical bioassay approaches and the challenges in implementing these critical bioanalytical tools to assess antibody bioactivity, stability, and structure-function.
Dr. Sandra Prior
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bioactivity
- Potency
- Bioassays
- Biological analytical methods
- Structure-function
- Mechanism of action
- Fc-effector functions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
